ReviewNigerian medical journal : journal of the Nigeria Medical Association
Clinicopathological significance of lymphovascular invasion in carcinoma breast and its correlation with other Prognostic markers: An experience at a tertiary care centre.
Review in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer is a biologically diverse condition that exhibits varied clinical outcomes and responses to treatment. Its prognosis and therapeutic approach are determined by several established factors, including the patient's age, tumor dimensions and site, histological classification and grade, and lymph node involvement, all of which must be evaluated collectively to guide optimal patient care. This research focuses on identifying and assessing lymphovascular invasion (LVI) through the use of D2-40 and CD34 immunohistochemical markers, aiming to explore its pathological relevance and its association with other prognostic indicators in breast carcinoma. Methodology: This study involved thirty eight mastectomy samples confirmed to have breast carcinoma. Using hematoxylin and eosin (H&E) stained sections, along with immunohistochemical (IHC) evaluation for markers including estrogen receptor (ER), progesterone receptor (PR), HER2/neu, and the vascular endothelial markers CD34 and D2-40, the relationship between lymphovascular invasion (LVI) and various prognostic factors was examined.CD34 and D2-40 were specifically utilized to distinguish lymphatic and blood vessels from retraction artifacts, aiding in the accurate identification of LVI. Statistical analysis was done by utilizing SPSS (Statistical Package for Social Sciences) version 24.0. Results: LVI had no statistical correlation with increased tumor size (P = 0.443), elevated Nottingham grade (P = 0.880), lymph node status (P = 0.420), or higher Nottingham Prognostic Index (NPI) (P = 0.733) and higher Lymph node ratio (LNR) (P = 0.097). Conclusion: D2-40 has emerged as a valuable immunohistochemical marker for identifying lymphatic endothelial cells. Given that lymphovascular invasion (LVI) is associated with unfavorable clinical outcomes, its assessment is essential in all cases of breast carcinoma to ensure accurate prognostication and appropriate therapeutic planning.
Indexed as
Identifiers
42605406PMC13477718What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.